Fortress Biotech, Inc. (FBIO)
3.23
+0.11
(+3.53%)
USD |
NASDAQ |
Mar 18, 12:12
Fortress Biotech Shareholders Equity (Quarterly) : 55.86M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 18.67B |
| Oramed Pharmaceuticals, Inc. | 203.28M |
| Avenue Therapeutics, Inc. | 3.557M |
| Lyell Immunopharma, Inc. | 248.20M |
| Climb Bio, Inc. | 160.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 181.41M |
| Total Liabilities (Quarterly) | 116.22M |
| Debt to Equity Ratio | 1.222 |
| Current Ratio | 2.192 |
| Net Debt Paydown Yield | 3.51% |